Crystal structure of outer membrane lipoprotein carrier protein (LolA) from Rickettsia bellii

Seattle Structural Genomics Center for Infectious Disease (SSGCID)

Outer membrane lipoprotein-sorting protein LolA

Morpheus Fusion F5: 20% v/v PEG 500 MME; 10 % w/v PEG 20000, 0.04M Imidazole; 0.06M MES monohydrate (acid) pH 6.5, 0.02M DL-Glutamic acid monohydrate; 0.02M DL-Alanine; 0.02M Glycine; 0.02M DL-Lysine monohydrochloride; 0.02M DL-Serine, 0.5% w/v 1,2,4-butanetriol, 0.5% w/v 1,2,6-hexanetriol, 0.5% w/v 1,5 -pentanediol, 0.5% w/v 1,1,1-tris(hydroxymethyl)propane, 0.5% w/v meso-erythritol, RibeA.17554.a.VH3.PW39215 at 28.3 mg/mL. Plate 13404 well F5 drop 2. Puck: PSL-0710, Cryo: direct

Seattle Structural Genomics Center for Infectious Disease
NIAID, National Institute of Allergy and Infectious Diseases

National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)

National Institutes of Health/Office of the Director

SSGCID, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, LolA, LIPID TRANSPORT